Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Upon binding EPO, the EPOR dimer changes conformation, resul...

Class:IdSummation:9030318
_displayNameUpon binding EPO, the EPOR dimer changes conformation, resul...
_timestamp2017-12-13 22:27:55
created[InstanceEdit:9030315] May, Bruce, 2017-11-27
modified[InstanceEdit:9032547] May, Bruce, 2017-12-13
textUpon binding EPO, the EPOR dimer changes conformation, resulting in activation of JAK2 associated with box 1 and box 2 of the cytoplasmic domain of each EPOR (inferred from mouse homologs). One JAK2 transphosphorylates 12 tyrosine residues of the other JAK2 thereby activating JAK2 to phosphorylate EPOR and other substrates (Arcasoy et al. 1999, Watowich et al. 1999, Erickson-Miller et al. 2000, and inferred from mouse homologs).
(summation)[Reaction:9006332] JAK2 transphosphorylates and is activated in response to Erythropoietin [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Upon binding EPO, the EPOR dimer changes conformation, resul... (9030318)